Summary
Ming Shi is a seasoned pharma executive with 14 years of experience leading strategy, market access, government affairs and commercial excellence across China, currently heading Government Affair, Market Access & Business Excellence at Organon. He has a proven track record driving large-scale transformations—securing NRDL inclusion for innovative drugs, navigating volume-based procurement, and integrating data analytics to turn insights into commercial impact. Prior roles at MSD and top consultancies (BCG, Booz, McKinsey) underpin his ability to translate complex policy and commercial challenges into sustainable business outcomes. Known for combining rigorous analytical depth from an engineering background with an MBA from Cornell, he blends operational discipline, digital innovation and stakeholder engagement to expand access and affordability in healthcare. An uncommon strength is his hands-on experience orchestrating high-profile government and industry events to shape policy narratives while delivering measurable commercial results.
14 years of coding experience
5 years of employment as a software developer
Master of Business Administration - MBA, Master of Business Administration - MBA at Cornell Johnson Graduate School of Management
Master, Electromagnetic Field & Microwave Technology, Master, Electromagnetic Field & Microwave Technology at Southeast University
English, Chinese